Michael A Palese, MD Email Michael Palese
- SITE CHAIR, DEPARTMENT OF UROLOGY | Mount Sinai Beth Israel
- PROFESSOR | Urology
- Hospital Affiliations
- Mount Sinai Beth Israel
- The Mount Sinai Hospital
- Mount Sinai St. Luke's and Mount Sinai West
- Mount Sinai Brooklyn
Dr. Michael A. Palese is Chair, Department of Urology, Mount Sinai Downtown- Union Square and Professor, Department of Urology at the Icahn School of Medicine at Mount Sinai. He is also the Director of Minimally Invasive Surgery of the Mount Sinai Health System and specializes in robotic, laparoscopic and endoscopic surgery.
As a board certified urologist and fellowship trained surgeon, he specializes in the diagnosis and treatment of kidney, ureter, adrenal, bladder and prostate disease with a special emphasis on robotic surgeries relating to kidney cancer.
Dr. Palese is a leading authority in the research and treatment of kidney disease specifically kidney cancer and kidney stones. He is one of a handful of surgeons in the United States who is trained in open, laparoscopic and robotic surgery. To date he has performed over 3000 open, laparoscopic and robotic kidney procedures.
Dr. Palese is a world recognized surgeon and scholar who is also a leader in the development of new treatments and technologies. He performed the first robotic radical nephrectomy, robotic partial nephrectomy, robotic donor nephrectomy, robotic nephroureterectomy, robotic adrenalectomy, and robotic ureteral reimplant & reconstruction at The Mount Sinai Medical Center in New York City. He holds several patents for the design of novel surgical devices.
Dr. Palese is the author of multiple book chapters and more than one hundred articles and abstracts. He is on the Medical Advisory Board of the National Kidney Foundation of Greater New York and is a reviewer and consultant for the periodicals of the Journal of Urology, Urology, Urologic Oncology and Journal of Endourology . He is an Editor for the Urologic Oncology (Journal): Seminars and Original Investigations in the section of New Technologies. He is on the steering committee for the Initiative on Kidney Cancer sponsored by the National Kidney Foundation. He also serves on the Medical Advisory Board to the New York Giants. He is a member of multiple organizations including the American Medical Association (AMA), the American Urological Association (AUA), the New York Section of the American Urological Association and the Society of Laparoscopic Surgeons (SLS).
Dr. Palese frequently lectures and presents his clinical research at national and international medical conferences. As a Visiting Professor he has performed live surgery and given clinical talks all over the United States, Austria, Argentina, Canada, Chile, France, Germany, India, Italy, Japan, Poland, Portugal, Spain, and the United Arab Emirates. He teaches and mentors college students, medical students, residents and fellows. He is a course director and faculty member for several educational courses to teach urologists and other physicians. In particular he is a faculty member for the annual Basic Laparoscopy Course sponsored by the American Urological Association in Houston, Texas. He has been a guest faculty member for Laparoscopy Courses in Buenos Aires, Argentina. He has also been the Course Director for several robotic surgery and advanced prostate courses
& workshops held at Mount Sinai. He has been featured in the news media on multiple occasions including the New York Times, Wall Street Journal, New York Daily News, CBS, CNN and WPIX TV.
Dr. Palese is included in the Castle Connolly Medical LTD America’s Top Doctors and Top Doctors for Cancer edition, The New York Times published Superdoctors and the New York Magazine’s annual Top Doctors issue.
Dr. Palese graduated from Cornell University in 1993 with a double major degree as well as a minor degree in Human Biology. He received his medical degree (M.D.) from The Mount Sinai School of Medicine in 1997. He completed his general surgery and urology residency at the University of Maryland Medical Center as well as performed research at the Johns Hopkins Hospital. He finished a fellowship in robotic and laparoscopic surgery at Weill Cornell Medical College of Cornell University in 2004.
In 2004, Dr. Palese joined the Mount Sinai Medical Center where he established the robot surgery program for the Department of Urology. He also served as the Chief of Urology at the North General Hospital in New York City from 2004-2008.
He is seeing patients at 5 E. 98th St – 6th floor and 625 Madison Ave – 2nd Floor.
Patient Story: http://www.mountsinai.org/patient-care/service-areas/urological-conditions-and-surgery/areas-of-care/kidney-cancer/patient-stories/i-owe-my-life-to-da-vinci-and-my-excellent-team-at-mount-sinai
American Board of Urology
- Benign Prostatic Hyperplasia
- Kidney Cancer
- Kidney Stones
- Prostate Cancer
- Prostate-Specific Antigen (PSA) Test
- Robot-Assisted Urologic Procedures
- Robotic Kidney Surgery
- Robotic Prostate Surgery
Anatomy, Biomechanics/Bioengineering, Kidney
MD, Mount Sinai School of Medicine
University of Maryland Medical Center
New York Presbyterian Hospital
English, French, German, Spanish
Society of Lapaoendoscopic Surgeons (SLS)
America's Top Doctors
Society Of Laparoendoscopic Surgeons (SLS)
America's Top Doctors for Cancer
Best Poster Presentation
Society of Laparoendoscopic Surgeons (SLS)
New York Magazine
Best Reviewer Award
Journal of Urology - Kidney Section
New York MetroArea Top Doctors
New York Times
Best Doctors in Ameriica
Laparoscopy, Robotic Surgery, Endoscopic Surgery, Kidney Stone Disease, Transplant Surgery, Kidney Cancer, Radio-frequency Ablation, Cryosurgery, Adrenal Cancer, Prostate Cancer, Bladder Cancer, Testicular Cancer, Kidney Reconstructive Surgery, Photoselective Vaporization of the Prostate (PVP), Benign Prostatic Hyperplasia (BPH), Erectile Dysfunction, and General Urology. Novel Surgical Devices, Holium Laser, GreenLight Laser, UroLift,
An International Phase 3, Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)
This research study is evaluating an experimental (investigational) drug called AGS-003 to see if it is effective against kidney cancer. An experimental drug has not been approved for use in the general population by the United States Food and Drug Administration (FDA). AGS-003 i...
Barman N, Palese M, Nair V, Herron D, Chin E, Palese M, LaPointe RD, Delaney V, Goldstein M, Florman S, Rocca J. Robotic-Assisted Laparoscopic Donor Nephrectomy of Patient With Nutcracker Phenomenon. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 2016 May;.
Barman N, Palese M, Tabrizian P, Franssen B, Yang M, Romanoff A, Hall S, Palese M, Sarpel U, Hiotis S, Labow D. Robotic-Assisted Laparoscopic Donor Nephrectomy of Patient With Nutcracker Phenomenon. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 2016 May;.
Finkelstein M, Bilal KH, Palese M. A Medical Application to Bridge the Gap between Clinicians and Clinical Data. Studies in health technology and informatics 2015; 210.
Small AC, Gainsburg DM, Mercado MA, Link RE, Hedican SP, Palese MA. Laparoscopic Needle-Retrieval Device for Improving Quality of Care in Minimally Invasive Surgery. Journal of the American College of Surgeons 2013 May;.
Gupta M, Akhavan A, Hall M, Palese M. Negative pressure pulmonary edema after laparoscopic donor nephrectomy. JSLS : Journal of the Society of Laparoendoscopic Surgeons / Society of Laparoendoscopic Surgeons 2012; 16(4).
Palese MA, Burnett AL. Corporoplasty using pericardium allograft (tutoplast) with complex penile prosthesis surgery. Urology 2001 Dec; 58(6): 1049-1052.
Tsao CK, Small AC, Kates M, Moshier EL, Wisnivesky JP, Gartrell BA, Sonpavde G, Godbold JH, Palese MA, Hall SJ, Oh WK, Galsky MD. Cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapy in the United States: a SEER analysis. World journal of urology 2012 Dec;.
Small AC, Tsao CK, Moshier EL, Gartrell BA, Wisnivesky JP, Godbold J, Sonpavde G, Palese MA, Hall SJ, Oh WK, Galsky MD. Trends and variations in utilization of nephron-sparing procedures for stage I kidney cancer in the United States. World journal of urology 2012 May;.
Kates M, Lavery HJ, Brajtbord J, Samadi D, Palese MA. Decreasing rates of lymph node dissection during radical nephrectomy for renal cell carcinoma. Annals of surgical oncology 2012 Aug; 19(8).
Hurt KJ, Musicki B, Palese MA, Crone JK, Becker RE, Moriarity JL, Snyder SH, Burnett AL. Akt-dependent phosphorylation of endothelial nitric-oxide synthase mediates penile erection. Proc Natl Acad Sci U.S.A 2002 Mar; 99(6): 4061-4066.
Tsao CK, Small AC, Moshier EL, Gartrell BA, Wisnivesky JP, Sonpavde G, Godbold JH, Palese MA, Hall SJ, Oh WK, Galsky MD. Trends in the use of cytoreductive nephrectomy in the United States. Clinical genitourinary cancer 2012 Sep; 10(3).
Lavery HJ, Small AC, Samadi DB, Palese MA. Transition from laparoscopic to robotic partial nephrectomy: the learning curve for an experienced laparoscopic surgeon. JSLS : Journal of the Society of Laparoendoscopic Surgeons / Society of Laparoendoscopic Surgeons 2011; 15(3).
Lavery HJ, Patel S, Palese M, Kasabian NG, Gainsburg DM, Samadi DB. Combined robotic radical prostatectomy and robotic radical nephrectomy. JSLS : Journal of the Society of Laparoendoscopic Surgeons / Society of Laparoendoscopic Surgeons 2010; 14(4).
Campbell SC, Palese MA. Laparoscopic cryoablation for a 3 cm nonhilar renal tumor. The Journal of urology 2011 Jan; 185(1).
Palese MA, Colonna JO, Chai TC. Donor to native ureteroureterostomy in a patient with preexisting ileal conduit during renal transplantation. Urology 2003 March; 61(3): 643.
Palese MA, Del Pizzo JJ, Munver R , Poppas DP. Robotic Assisted Adult and Pediatric Pyeloplasty. In: Textbook of Laparoscopic Urology. 2004.
Palese MA, Crone JK, Burnett AL. A castrated mouse model of erectile dysfunction. J Androl 2003 Sep; 24(5): 699-703.
Musicki B, Palese MA, Crone JK, Burnett AL. Phosphorylated endothelial nitric oxide synthase mediates vascular endothelial growth factor-induced penile erection. Biol Reprod 2004 Feb; 70(2): 282-289.
Palese MA, Ferrer F , Perlman E , Gearhart JP. Metanephric stromal tumor: A rare benign pediatric renal mass. Urology 2001 Sep; 58(3): 462.
Palese M, Wedmid A. Complications of Laparoscopic Donor Nephrectomy. . In: Complications of Laparoscopic and Robotic Urologic Surgery. . Springer, New York; pp127-142.
Palese M, Del Pizzo J, Munver R, Poppas D. Robotic assisted adult and pediatric pyeloplasty. . In: Textbook of Laparoscopic Urology. Informa Healthcare, New York, ; pp303-311.
Palese M, Mullhall J, Goldstein I. Surgical treatments for vasculogenic erectile dysfunction. . In: Atlas of Male Sexual Dysfunction. Current Medicine LLC, Philadelphia, , pp115-125.
Palese MA, Small AC. Ethanol Injection of Prostate. . In: Treatment of Benign Prostatic Hyperplasia: Modern Alternative to Transurethral Resection of the Prostate.. Springer, New York, ; pp163-172.
Palese MA, Mulhall JP, Goldstein I . Surgical Treatments for Vasculogenic Erectile Dysfunction. In: Atlas of Male Sexual Dysfunction. Philadelphia, 2004. pp115-125.
Palese MA, Su LM, Kavoussi L. Laparoscopic retroperitoneal lymph node dissection after chemotherapy. Urology 2002 July; 60(1): 130-134.
Lubezky N, Stern E, Nair V, Herron D, Chin E, Palese M, LaPointe RD, Delaney V, Goldstein M, Florman S, Rocca J. Pulmonary embolus originating from renal vein stump thrombus after laparoscopic living donor nephrectomy case report.. Transplant Proc. 2014 September; 46(7): 2406-8.
Leapman M, Jihara G, Tabrizian P, Franssen B, Yang M, Romanoff A, Hall S, Palese M, Sarpel U, Hiotis S, Labow D. Genitourinary Resection at the Time of Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis is not Associated with Increased Morbidity or Wosened Oncologic Outcomes: A Case Matched Study . Ann Surg Oncol. 2014 April; 21(4): 2406-8.
Harvey K, Palese M, Palese M. Ablative Therapies for Small Renal MAsses. Contemporary Oncology May; 5(10: 10-14.
Barman N, Palese M. Robotic-Assisted Laparoscopic Donor Nephrectomy of Patient With Nutcracker Phenomenon. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 2016 May;.
Yang A, Barman N, Chin E, Herron D, Arvelakis A, LaPointe Rudow D, Florman SS, Palese MA. Robotic-assisted vs. laparoscopic donor nephrectomy: a retrospective comparison of perioperative course and postoperative outcome after 1 year. Journal of robotic surgery 2017 Aug;.
Levy I, Finkelstein M, Bilal KH, Palese M. Modified frailty index associated with Clavien-Dindo IV complications in robot-assisted radical prostatectomies: A retrospective study. Urologic oncology 2017 Jun; 35(6).
Pak JS, Lee JJ, Bilal K, Finkelstein M, Palese MA. Utilization Trends and Short-term Outcomes of Robotic Versus Open Radical Cystectomy for Bladder Cancer. Urology 2017 May; 103.
Pak JS, Lee JJ, Bilal K, Finkelstein M, Palese MA. Utilization trends and outcomes up to 3 months of open, laparoscopic, and robotic partial nephrectomy. Journal of robotic surgery 2017 Jun; 11(2).
Finkelstein M, Bilal K, Palese M. Trends in Subspecialization Within Inpatient Urology From 1982 to 2012. Urology 2016 Dec; 98.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Palese during 2017 and/or 2018. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
- C.R. Bard, Inc.
Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose
- Intuitive Surgical, Inc.
Other activities: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- American Medical Systems (AMS)
- Intuitive Surgical, Inc.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.